Stock IPH INNATE PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Innate Pharma

Equities

IPH

FR0010331421

Real-time Euronext Paris
Other stock markets
 08:58:05 03/07/2024 BST 		5-day change 1st Jan Change
1.996 EUR +1.73% Intraday chart for Innate Pharma +1.32% -23.82%
06-17 Sanofi: positive phase 1/2 data in leukemia CF
06-17 Innate: positive phase 1/2 data in leukemia CF
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INNATE PHARMA Stock Innate Pharma
 171M - -
MODERNA, INC. Stock Moderna, Inc.
 44.87B - - - - -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.8B
LONZA GROUP AG Stock Lonza Group AG
 37.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.32B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.4B
  1. Stock Market
  2. Equities
  3. IPH Stock
  4. Charts Innate Pharma
  5. Sector Chart